Biotech entity
pharma is the sole category represented across all 2 tracked stories. Budi Gunadi Sadikin is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 114-day window averages about 0.1 stories each week. Each story carries 2 original sources on average, compared with 3.8 for the broader beat in this window.
Last mentioned: Jul 13, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 2 tracked stories. Budi Gunadi Sadikin is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 114-day window averages about 0.1 stories each week. Each story carries 2 original sources on average, compared with 3.8 for the broader beat in this window. At 7, the average consequence score sits above the same-window beat average of 6.4. ASEAN appears in 2 tracked Biotech stories published from March 22, 2026 through July 13, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 148 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering ASEAN. Shared-story counts are live from our verified record — not editorial picks.
Gateway Designation
Official recognition of the southern frontier as the primary medical AI hub for ASEAN trade.
Pilot Programs
Initial cross-border medical AI diagnostic trials launched with Vietnam and Thailand.
Infrastructure Build-out
Expansion of 5G and data center capacity in Guangxi and Yunnan provinces.
Takeda receives Indonesia’s first plasma fractionation license, part of a $30 million collaboration to build a domestic plasma ecosystem. The initiative aims to scale manufacturing of plasma-derived medicinal products, positioning Indonesia as a regional biopharma hub.
Source: Business Wire (ca) · Business Wire (ca)
China is strategically positioning its southern border regions as a digital gateway to export medical AI technologies to the ASEAN region. This initiative leverages advanced infrastructure and geographic proximity to provide scalable, AI-driven healthcare solutions across Southeast Asia.
ASEAN is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
